The project ORCHESTRA aims to efficiently generate rigorous evidence to improve the prevention and treatment of COVID-19 and to rapidly provide a structured platform to test vaccine as soon as…
Gianni Ferraretto, an Italian filmmaker, visited Kampala, Uganda three times between 2009 and 2019 to uncover the story of young people living with HIV.
On November 12th, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending marketing authorisation for dolutegravir 5mg dispersible tablets…
In the spirit of World Antimicrobial Awareness Week, we’d like to share a summary of the findings from the “Implementation and Impact of Paediatric Antimicrobial Stewardship Programs: A Systematic Scoping…
Professor Irja Lutsar, a prominent and active member of the Penta network for many years, has been elected as Estonia’s Woman of the Year by the Business and Professional Women…
Louise Hill presented the findings of a NeoVanc sub-study at ESPID’s 2020 Virtual Meeting in late October. Below is a summary of the study and findings.
Penta is the lead of the Clinical Research Working Group for the newly launched Global Accelerator for Paediatric Formulations (GAP-f), a network led by the World Health Organisation.
The c4c project, co-coordinated by Penta together with Janssen, Bayer and the University of Liverpool, has had its first review, titled “European research networks to facilitate drug research in children”,
Authors: Elena Mozzo; Valentina Ortolan; Elena Badio; Federica Batterman; and Chiara Novello In October 2019, Penta began hosting HIV educational sessions in 5 high schools in Padova,
Now is the time to “Speak up for health worker safety!” Working in stressful environments makes health workers more prone to errors which can lead to patient harm.
Penta has been invited to run a one-day session at the Republican Hospital of Infectious Diseases, St Petersburg conference on ‘Actual problems of HIV Infection: Mother and Child’ on Tuesday…
Through 6 distinctive sessions, the WSC Spotlight will give an overview of the global epidemiology and burden of sepsis and AMR, exploring innovative, novel, and cost-effective approaches for the prevention…
Last Patient Last Visit (LPLV) completed for the Penta 17 Strategy for Maintenance of HIV suppression with integrase inhibitor + darunavir/ritonavir in children (SMILE) trial.